OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $599,992 Invested

2025

Biogen

Alexis Moscoso, PhD

Longitudinal Study with Positron Emission Tomography Using [¹⁸F]PI-2620 in Primary Tauopathies

  • Funding Amount: $599,992
  • Organization Type:
  • Program: Biomarkers
  • Target: Tau
  • Status: Active